OBIO insider disclosures
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
| Taylor Andrew Lawrence Chief Financial Officer · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Common Stock, par value $0.0001 per share · Direct ownership · Reported balance after transaction: 587913 · Securities delivered or withheld for tax or exercise payment · Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations. | 2026-11-20 | 2026-11-20 | 3,076 shares/units | SEC 4 | Follow |
Joint filing · 2 reporting ownersOrchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 10756063 · SEC code covers open-market or private transactions · Held by certain affiliated funds (the "RTW Funds") managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their respective pecuniary interests therein. | 2026-11-09 | 2026-11-12 | ≈ $6,000,000.00 1,200,000 shares/units | SEC 4 | From owner profile |
| Fain Eric S Director · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock, par value $0.0001 per share · Indirect ownership · By the Fain Living Trust · Reported balance after transaction: 119630 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share. | 2026-11-09 | 2026-11-09 | ≈ $100,000.00 20,000 shares/units | SEC 4 | Follow |
| Pacitti David Director · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock, par value $0.0001 per share · Direct ownership · Reported balance after transaction: 74750 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share. | 2026-11-09 | 2026-11-09 | ≈ $100,000.00 20,000 shares/units | SEC 4 | Follow |
| Hochman David P See Remarks · Director · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Indirect ownership · By the DPH 2008 Trust · Reported balance after transaction: 437916 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share. · Chief Executive Officer and Chairperson | 2026-11-09 | 2026-11-09 | ≈ $25,000.00 5,000 shares/units | SEC 4 | Follow |
| Taylor Andrew Lawrence Chief Financial Officer · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock, par value $0.0001 per share · Direct ownership · Reported balance after transaction: 590989 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share. | 2026-11-09 | 2026-11-09 | ≈ $5,000.00 1,000 shares/units | SEC 4 | Follow |
| Sherman Darren See Remarks · Director · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | SellFiling detailsSEC transaction code S Common Stock, par value $0.0001 per share ("Common Stock") · Direct ownership · Reported balance after transaction: 1104402 · SEC code covers open-market or private transactions · The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. · The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $5.66 to $5.995. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote. · President and Chief Operating Officer | 2026-11-02 | 2026-11-03 | ≈ $86,100.00 15,000 shares/units | SEC 4 | Follow |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.